Hydrocortisone Butyrate Production Cost Reports

The report provides a detailed analysis essential for establishing a Hydrocortisone Butyrate production plant. It encompasses all critical aspects necessary for Hydrocortisone Butyrate production, including the cost of Hydrocortisone Butyrate production, Hydrocortisone Butyrate plant cost, Hydrocortisone Butyrate production costs, and the overall Hydrocortisone Butyrate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Hydrocortisone Butyrate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Hydrocortisone butyrate is a prescription-strength, moderately potent topical corticosteroid utilised in pharmaceutical production as an active pharmaceutical ingredient (API). It is used for formulating creams, ointments, lotions, and solutions used to treat inflammatory skin conditions like eczema, psoriasis, atopic dermatitis, and seborrheic dermatitis. It is used to relieve redness, itching, swelling, and pruritus through its anti-inflammatory and immunosuppressive mechanisms. In research and development, it functions in advanced drug delivery systems such as PLGA nanoparticles and solid lipid nanoparticles to enhance skin penetration and efficacy, along with combination therapies like excimer laser treatments for vitiligo.

Hydrocortisone butyrate market growth is propelled by the rising prevalence of dermatological disorders such as eczema, psoriasis, and atopic dermatitis, which increases demand for effective topical corticosteroids. Advancements in drug delivery systems, including nanotechnology, microencapsulation, and nanoparticle formulations like PLGA and solid lipid nanoparticles, enhance its skin permeation, stability, and bioavailability, driving innovation and therapeutic efficacy. Additionally, heightened patient awareness, ageing populations, expanded healthcare access in regions like the Asia-Pacific, and strategic collaborations for combination therapies further boost market expansion. However, stringent FDA and international approval processes delay procurement timelines, while competition from generics and side effect concerns push for high-purity, innovative suppliers, influencing industrial hydrocortisone butyrate procurement.

Raw Material for Hydrocortisone Butyrate Production

According to the Hydrocortisone Butyrate production plant project report, the various raw materials for Hydrocortisone Butyrate production include hydrocortisone acetate and butyryl chloride.

Production Process of Hydrocortisone Butyrate

The extensive Hydrocortisone Butyrate production cost report consists of the following major industrial production process:

1. Production via a two-step chemical process: The production process of hydrocortisone butyrate occurs via a two-step process starting from hydrocortisone acetate. In the first step, hydrocortisone acetate undergoes selective acylation with butyryl chloride in an organic solvent like dichloromethane, catalysed by DMAP or pyridinium salts at 0–5 degree Celsius. The reaction is followed by acidification to pH <5 and recrystallisation to yield hydrocortisone 17-butyrate 21-acetate intermediate. The second step involves selective hydrolysis of the 21-acetate group using a mild inorganic base such as alkali-metal carbonate in another organic solvent, with controlled temperature and addition rate to preserve the 17-butyrate ester. The process finally produces high-purity hydrocortisone 17-butyrate after purification by crystallisation.

Properties of Hydrocortisone Butyrate

Hydrocortisone butyrate (hydrocortisone 17-butyrate) is a white to off-white crystalline solid with molecular formula C25H36O6, molecular weight 432.56 g/mol. It has a melting point in the range of 209–214 degree Celsius, density ~1.09 g/cm³, and limited solubility in water but good in chloroform and methanol, ideal for topical formulations. It has a pKa ~12.98, logP ~3.5 for lipophilicity, and a tetracyclic steroidal structure with Δ4-3-keto and 11β-hydroxy groups, stable under refrigeration per USP/EP standards (97–102% purity), and identifiable via characteristic NMR, MS (m/z 121 base peak), and HPLC in quality control.